From: Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
Sequences | Amplicon size | Restriction enzyme | Reference | |
---|---|---|---|---|
CYP2C9*2 | ||||
Forward | 5′-CACTGGCTGAAAGAGCTAACAGAG-3′ | 375 bp | AvaII | [22] |
Reverse | 5′-GTGATATGGAGTAGGGTCACCCAC-3′ | |||
CYP2C9*3 | ||||
Forward | 5′-TGCACGAGGTCCAGAGGTAC-3′ | 105 bp | KpnI | [22] |
Reverse | 5′-ACAAACTTACCTTGGGAATGAGA-3′ | |||
CYP4F2 | ||||
Forward | 5′-CGGAACTTGGACCATCTACA-3′ | 439 bp | PvuII | [14] |
Reverse | 5′-CCTACTCTCCCACAGGCATTA-3′ | |||
VKORC1 | ||||
Forward | 5′-ATCCCTCTGGGAAGTCAAGC-3′ | 636 bp | NciI | [23] |
Reverse | 5′-CACCTTCAACCTCTCCATCC-3′ |